Hypofractionated radiotherapy for early breast cancer: Review of phase III studies

Reports of Practical Oncology and Radiotherapy

Volumn 17, Issue 2, 2012, Pages 66-70

  Kacprowska, Agata ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adjuvant radiotherapy; Breast cancer; Hypofractionated radiotherapy

Indexed keywords

ESTROGEN RECEPTOR; TRASTUZUMAB;

AGE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HYPOFRACTIONATED RADIOTHERAPY; LYMPH NODE METASTASIS; MASTECTOMY; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84859722915     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.10.003     Document Type: Review

References (23)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, wand lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
2. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
3. Poggi M.M., Danforth D.N., Sciuto L.C., et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer 2003, 98:697-702.
4. Van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
5. Blichert-Toft M., Nielsen M., During M., et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008, 47:672-681.
6. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
7. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001, 345:1378-1387.
8. Bartelink H., Horiot J.C., Poortmans P., et al. Impact of higher radiation dose of local control and survival in breast-conserving therapy of early breast cancer: 10-years results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25:3259-3265.
9. Virnig B., Habermann E., AlRaie W., et al. Increased-use of breast-conserving surgery: preferred treatment or failure to provide adequate treatment?. Breast Cancer 2007, 106(Suppl. 1):S188.
10. Athas W., Adams-Cameron M., Hunt W., et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000, 92:269-271.
11. Ballard-Barbash R., Potosky A.L., Harlan L.C., et al. Factors associated with surgical and radiation therapy for early-stage breast cancer in older woman. J Natl Cancer Inst 1996, 88:716-726.
12. Joslyn S.A. Radiation therapy and patient age in the survival from early-stage breast cancer. Int J Radiat Oncol Biol Phys 1999, 44:821-826.
13. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomized trial. Radiother Oncol 2005, 75:9-17.
14. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patient with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006, 7:467-471.
15. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term result of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
16. The START Trialists' Group: the UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341.
17. The START Trialists' Group: the UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 371:1098-1107.
18. Yarnold J., Bloomeld D., LeVay J. Prospective randomized trial testing 5.7Gy and 6.0Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol 2004, 16:s30.
19. Brunt A.M., Yarnold J. A five fraction regimen for women with early breast cancer: first analysis of the randomized UK FAST trial. Eur J Canc Suppl 2009, 7:2.
20. Hooning M.J., Botma A., Aleman B.M.P., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007, 99:365-375.
21. Smith B.D., Bentzen S.M., Correa C.R., et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 81:59-68.
22. Holloway C.L., Panet-Raymond V., Olivotto I. Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery. Breast 2010, 19:163-167.
23. Goldhirsch A., Wood W.C., Coates A.S., et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011, 22:1736-1747.